Pre-Operative Hormone Therapy for Postmenopausal Women With ER and/or PgR Positive Breast Cancer: An Uncontrolled Phase IIb/III Trial to Assess Optimal Duration of Pre-Operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers.
Phase of Trial: Phase II/III
Latest Information Update: 11 Feb 2011
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 06 Nov 2007 New trial record.